EspeRare is a not-for-profit organization established in Switzerland and recognized to be operating in the public interest. In collaboration with patient groups and other key stakeholders, EspeRare focuses on rescuing and repositioning discontinued therapies with high potential to address severe and currently neglected therapeutic needs of children affected by rare genetic diseases. EspeRare is using its pharma R&D expertise and patient-centric model to advance novel treatments for the undeserved patients, thus bringing hope for better future to these children and their families.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 15 Avenue Sécheron, Genève,genève 1202,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- esperare.org
- Keywords
- Rare diseases, Drug discovery, Drug development, Patient centered, Biotechnology, Genetics, Biotechnology, Research & Development, Genetic diseases, pediatric, prenatal, data science, drug repositioning.
- HQ
- Genève, Genève
Esperare Foundation Questions
Esperare Foundation's website is esperare.org
Esperare Foundation's LinkedIn profile is https://ch.linkedin.com/company/esperare-foundation
Esperare Foundation has
13 employees.
View email and phone details for 13
employees at Esperare Foundation.
Esperare Foundation's industry is
Biotechnology Research
Esperare Foundation's top competitors are
Ashoka,
Ass Pour La Promotion Du Centre Scolaire De L'hopital Necker-Enfants Malades,
Peace Initiatives,
Hug - Hopitaux Universitaires De Genève,
Merck Healthcare,
Pxe International,
Les Circuits Des Rêveurs,
College La Croix Menee,
Pierre Fabre Laboratories,
Jouvene.
Esperare Foundation's categories are Biotechnology Research
Esperare Foundation's founding year is 2013
